ScripsAmerica to Present at the Wall Street Analyst Forum's 25th Annual Institutional Investor Conference

TYSONS CORNER, Va.--()--ScripsAmerica, Inc. (OTCBB: SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, today announced that Bob Schneiderman, Chief Executive Officer and Founding Partner, will be presenting at the Wall Street Analyst Forum’s 25th Annual Institutional Investor Conference. This conference will be held at the University Club in New York, NY on Thursday, March 19, 2015.

Mr. Schneiderman said, "We are very pleased that the Wall Street Analyst Forum has invited us to this important conference that draws many of the leading investors in our market. This is an excellent venue in which to tell our story to an audience that recognizes the value being created in our industry."

In addition to the Company’s presentation, the conference will offer investors an opportunity to participate in a 40 minute break-out session with Bob Schneiderman.

About ScripsAmerica, Inc.

ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.

Contacts

Gregory FCA
Joe Hassett, 610-228-2110
joeh@gregoryfca.com

Release Summary

ScripsAmerica to Present at the Wall Street Analyst Forum's 25th Annual Institutional Investor Conference

Contacts

Gregory FCA
Joe Hassett, 610-228-2110
joeh@gregoryfca.com